Validation of a questionnaire for self-rating of urological and gynaecological morbidity after treatment of gynaecological cancer

Radiotherapy and Oncology

Volumn 65, Issue 1, 2002, Pages 29-38

  Jensen, Pernille Tine ^a,b   Klee, Marianne Carol ^c   Groenvold, Mogens ^b,d  

^a Rigshospitalet   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Gynaecological cancer; Patient observer agreement; Questionnaire; Urological morbidity; Validation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERROR; FEMALE; GYNECOLOGIC CANCER; GYNECOLOGIC DISEASE; HUMAN; INTERVIEW; MEDICAL LITERATURE; MENOPAUSE; MORBIDITY; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; SYMPTOM; URINARY TRACT DISEASE; VALIDATION PROCESS;

ADULT; AGED; FEMALE; GENITAL NEOPLASMS, FEMALE; HEALTH STATUS INDICATORS; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SELF ASSESSMENT (PSYCHOLOGY); SELF-EXAMINATION; STATISTICS, NONPARAMETRIC;

EID: 0036806078     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00263-3     Document Type: Article

References (32)

1. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 85:1993;365-376.
2. Altman D.G. Some common problems in medical research. Altman D.G., Practical statistics for medical research. 1st ed. 1991;396-439 Chapman & Hall, London.
3. Anacak Y., Yalman D., Ozsaran Z., Haydaroglu A. Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems. Int J Radiat Oncol Biol Phys. 50:2001;1107-1112.
4. Bowling A. Measuring health: a review of quality of life measurement scales. 1991;Open University Press, Milton Keynes.
5. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol. 26:1993;195-202.
6. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
7. Cull A., Howat S., Greimel E., et al. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. Eur J Cancer. 37:2001;47-53.
8. Cull A., Sprangers M.A., Bjordal K., Aaronson N.K. EORTC Quality of Life Study Group translation procedure. 1998;EORTC, Brussels.
9. Denekamp J., Bartelink H., Rubin P. Correction for the use of the SOMA LENT tables. American and European LENT Working Committees. Radiother Oncol. 39:1996;191.
10. Fayers P.M., Machin D. Scores and measurements: validity, reliability, sensitivity. Fayers P.M., Machin D., Quality of life: assessment, analysis and interpretation. 1st ed. 2000;45-71 John Wiley & Sons Ltd, West Sussex, England.
11. Feinstein A.R., Cicchetti D.V. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 43:1990;543-549.
12. Fujikawa K., Miyamoto T., Ihara Y., Matsui Y., Takeuchi H. High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women. Gynecol Oncol. 80:2001;21-23.
13. Groenvold M., Bjorner J.B., Klee M.C., Kreiner S. Test for item bias in a quality of life questionnaire. J Clin Epidemiol. 48:1995;805-816.
14. Groenvold M., Klee M.C., Sprangers M.A., Aaronson N.K. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 50:1997;441-450.
15. Jensen P.T., Roed H., Engelholm S.A., Rosendal F. Pulsed dose rate (PDR) brachytherapy as salvage treatment of locally advanced or recurrent gynecologic cancer. Int J Radiat Oncol Biol Phys. 42:1998;1041-1047.
16. Juniper E.F., Guyatt G., Jaeschke R. How to develop and validate a new health-related quality of life instrument. Spilker B., Quality of life and pharmacoeconomics in clinical trials. 2nd ed. 1996;49-56 Lippencutt-Raven, Philadelphia.
17. Klee M., Thranov I., Machin D. Life after radiotherapy: the psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecol Oncol. 76:2000;5-13.
18. Klee M., Thranov I., Machin P.D. The patients' perspective on physical symptoms after radiotherapy for cervical cancer. Gynecol Oncol. 76:2000;14-23.
19. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics. 33:1977;159-174.
20. Marks L.B., Carroll P.R., Dugan T.C., Anscher M.S. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 31:1995;1257-1280.
21. Osoba D., Zee B., Pater J., Warr D., Kaizer L., Latreille J. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res. 3:1994;353-364.
22. Pavy J.J., Denekamp J., Letschert J., et al. EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys. 31:1995;1043-1047.
23. Pedersen D., Bentzen S.M., Overgaard J. Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system. Radiother Oncol. 28:1993;134-141.
24. Pedersen D., Bentzen S.M., Overgaard J. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 29:1994;941-952.
25. Ralph G., Tamussino K., Lichtenegger W. Urological complications after radical hysterectomy with or without radiotherapy for cervical cancer. Arch Gynecol Obstet. 248:1990;61-65.
26. Rubin P., Constine L.S. III, Fajardo L.F., Phillips T.L., Wasserman T.H. EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol. 35:1995;9-10.
27. Sprangers M.A., Aaronson N.K. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol. 45:1992;743-760.
28. Sprangers M.A., Cull A., Groenvold M. EORTC Quality of Life Study Group: guidelines for developing questionnaire modules. 2nd ed. 1998;EORTC, Brussels.
29. Sprangers M.A., Cull A., Groenvold M., Bjordal K., Blazeby J., Aaronson N.K. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual Life Res. 7:1998;291-300.
30. Streiner D.L., Norman G. Health measurement scales, a practical guide to their development and use, editors. 2nd ed. 1995;Oxford University Press, New York.
31. Wagner J.R., Russo P. Urologic complications of major pelvic surgery. Semin Surg Oncol. 18:2000;216-228.
32. Zola P., Maggino T., Sacco M., Rumore A., et al. Prospective multicenter study on urologic complications after radical surgery with or without radiotherapy in the treatment of stage IB-IIA cervical cancer. Int J Gynecol Cancer. 10:2000;59-66.